San Francisco–based Ossium Health has carried out three transplants for cancer patients using stem cells from deceased donors ...

Researchers have identified a key weakness in acute myeloid leukemia, offering a promising new strategy to delay the ...

A treatment of acute myeloid leukemia being developed by Sanofi (SNY) US Services was granted FDA orphan designation, according to a post to the agency’s website. Published first on TheFly – the ...

(RTTNews) - Syndax Pharmaceuticals, Inc. (SNDX), Tuesday announced positive results from the relapsed or refractory mutant NPM1 acute myeloid leukemia cohort in the pivotal Phase 2 portion of the ...

In the phase 2 portion of the phase 1/2 AUGMENT-101 trial, 12 of 64 patients with relapsed or refractory mutant NPM1 acute ...

Oct. 9, 2024 — Researchers have created a CRISPR-based rapid molecular diagnostic for two forms of leukemia that are driven by mutations that involve gene fusions. The technology accurately ...

Dr Stephen Ma – Developing a cancer vaccine against acute myeloid leukaemia With dual haematology (RACP / RCPA) advanced training, Dr Stephen Ma has and worked at several Victorian tertiary centres ...

WHEELING, W.Va. — Govenor Jim Justice joined West Virginia Tourism Secretary Chelsea Ruby and other officials in Wheeling to present a $4.4 million AML Economic Revitalization grant in support ...

Novartis has received US Food and Drug Administration (FDA) accelerated approval for Scemblix (asciminib) to treat adults with newly diagnosed Philadelphia chromosome-positive chronic myeloid ...

The family of a young girl who has battled leukaemia since the age of five have described how they were able to find joy through their champion racehorse, Kitty's Light. Betsy, now aged 7 ...